Cancer Research Targets Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 6113-6117, December 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takaku, K.
Right arrow Articles by Taketo, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takaku, K.
Right arrow Articles by Taketo, M. M.
[Cancer Research 59, 6113-6117, December 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Gastric and Duodenal Polyps in Smad4 (Dpc4) Knockout Mice1

Kazuaki Takaku, Hiroyuki Miyoshi, Akihiro Matsunaga, Masanobu Oshima, Nobuya Sasaki and Makoto M. Taketo2

Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033 [K. T., A. M., N. S., M. M. T.], and Banyu Tsukuba Research Institute (Merck), Tsukuba, Ibaraki 300-2611 [H. M., M. O.], Japan


   ABSTRACT
Top
 ABSTRACT
Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
The SMAD4 (DPC4) gene was initially isolated as a candidate tumor suppressor from the convergent site of homozygous deletions on 18q in a panel of pancreatic carcinoma cell lines. It encodes a common cytoplasmic signaling molecule shared by the transforming growth factor-{beta}, activin, and bone morphogenic pathways. We recently inactivated its mouse homologue Smad4 and demonstrated its role in the malignant progression of benign adenomas to invasive adenocarcinomas by analyzing mice with Apc and Smad4 compound mutations. Although simple Smad4 homozygotes were embryonically lethal, the heterozygotes were fertile and appeared normal up to the age of 1 year. Upon further investigation, however, they have developed inflammatory polyps in the glandular stomach and duodenum. By PCR genotyping and immunohistochemical staining, the wild-type Smad4 allele has been lost in the polyp epithelial cells, i.e., loss of heterozygosity. On the other hand, we have not found any mutations in such genes as K-Ras, H-Ras, N-Ras, p53, or PTEN. Histologically, the polyps are similar to human juvenile polyps showing moderate stromal cell proliferation and infiltrations by eosinophils and plasma cells. In addition, foci of adenocarcinoma with signet ring cells are also found. These results are consistent with a recent report that germ-line SMAD4 mutations are found in a subset of familial juvenile polyposis.


   Introduction
Top
 ABSTRACT
 Introduction
Materials and Methods
 Results
 Discussion
 REFERENCES
 
Mutations in the SMAD4 (DPC4) gene located on chromosome 18q21 are associated with not only pancreatic cancer (1) but also colorectal carcinoma (2) . SMAD4 belongs to the SMAD gene family involved in the signal transduction pathways that are activated through the TGF3 -{beta} family receptors (3, 4, 5) . Although TGF-{beta} suppresses normal cell growth, tumors acquire resistance to TGF-{beta} by several mechanisms relatively late in tumorigenesis, usually correlating with invasive changes (6) . For example, decreased expression or mutation of TGF-{beta} type II receptor has been observed in cancer cell lines (7) . In addition, LOH and mutations in the SMAD4 gene were reported in invasive and metastatic carcinomas (8) . We demonstrated recently that homozygous inactivation of the Smad4 gene causes the polyp adenomas in the Apc mutant mice to progress into invasive and malignant adenocarcinomas (9) . The strategy was based on the findings that mouse Smad4 and Apc are mapped on the same chromosome (chromosome 18), 30 cM apart, and that Apc LOH involves loss of the entire chromosome.

Familial juvenile polyposis is an autosomal dominant disease in which individuals are predisposed to inflammatory polyps and gastrointestinal cancer (10) . Recently, a subset of juvenile polyposis patients was reported to carry germ-line mutations in the SMAD4 gene (11 , 12) . Many of the patients had a 4-bp deletion in exon 9 of the SMAD4 gene, which caused a truncation in the MH2 domain near the COOH terminus, resulting in defective signal transduction. Interestingly, another subset of juvenile polyposis patients was reported to carry mutations in the PTEN gene located on chromosome 10q23 and encoding a phosphatidylinositol 3,4,5-phosphate phosphatase (13 , 14) . The heterozygous Pten knockout mice, however, show pathological characteristics similar to Cowden disease and its related syndromes, which are caused by mutations in the PTEN gene (15) .

Regarding our Smad4 knockout mice (9) , the heterozygotes were fertile and appeared normal up to the age of about 1 year, although homozygous mutants were embryonically lethal. Here we report that, upon further observation, the heterozygous mice older than 1 year have developed multiple gastric and duodenal polyps that show much similarity to those in human juvenile polyposis.


   Materials and Methods
Top
 ABSTRACT
 Introduction
 Materials and Methods
Results
 Discussion
 REFERENCES
 
Generation of Smad4 Knockout Mice.
The heterozygous knockout mice we reported recently (9) were originally in the mixed background between 129/Sv and C57BL/6N. They were backcrossed further to the C57BL/6N for six generations.

Polyp Scoring.
The number and size of the polyps were scored by a single examiner (K. T.) as described (9 , 16 , 17) .

PCR Detection of Smad4 LOH.
Epithelial cells were collected as described earlier (9 , 16) . Primers used were DPC4F1, PGKR, and DE1R1, as described previously (9) .

Histochemical Analysis.
Samples were fixed, sectioned, and stained with H&E or Alcian blue (pH 2.5) as described previously (9) . Staining with the periodic acid-Schiff reagent was performed according to Mowry (18) .

Immunohistochemistry.
Essentially the same procedures were used as described previously (9 , 17) . Samples were stained with the following antibodies: goat polyclonal antibodies against SMAD4 COOH- and NH2-terminal peptides, respectively (identical to corresponding mouse sequences; C-20 and N-16, respectively; Santa Cruz Biotechnology); a rabbit polyclonal antibody against human TGF-{beta}1 (identical to the corresponding mouse sequence; Santa Cruz Biotechnology); a rabbit polyclonal antibody against human TGF-{beta} receptor type II (cross-reacting with the mouse protein; Santa Cruz); a rabbit polyclonal antibody against human adenomatous polyposis coli (cross-reacting with the mouse protein; Santa Cruz Biotechnology); and a rabbit polyclonal antibody against the COOH-terminal residues (amino acids 768–781) of human {beta}-catenin but identical to the corresponding mouse sequence (Sigma Chemical Co.).

Sequencing Analyses.
The genomic gene segments for the mutational hot spots at codons 12, 13, and 61 of the K-Ras (Kras2), H-Ras (Hras1), and N-Ras (Nras) were amplified by PCR and sequenced as described previously (19) . The coding sequence for the p53 gene was determined as described (20) . The genomic sequence of Pten for the central two-thirds of the coding region was amplified and sequenced as described (21) .


   Results
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
Discussion
 REFERENCES
 
We earlier found that the mouse Smad4 (Dpc4) gene maps on chromosome 18, 30 cM distal from Apc. We then inactivated the gene in ES cells by homologous recombination and established a germ line-transmitted mutant strain (9) . Although the homozygotes were embryonically lethal, the heterozygotes were fertile and appeared normal up to the age of ~1 year. Upon examination of 1.5-year-old Smad4 heterozygotes, however, we recently found multiple gastric polyps in all six mice, whereas no such polyps were found in the wild-type littermates. Accordingly, we examined more mice of 25, 30, 50, 65, 75, 85, and 100 weeks of age, respectively (Table 1)Citation . At the age of 100 weeks (close to 2 years), gastric polyps were found in all eight mice examined, whereas 3 of 15 mice had such polyps at the age of 50 weeks (~1 year). The polyp multiplicity ranged from one to three per stomach. When 15 heterozygotes at 25 or 30 weeks were examined extensively, however, no polyps were found in any mice. As shown in Fig. 1ACitation , the gastric polyps were found in the glandular part of the stomach, often in the pyloric region. They showed a pedunculate or sometimes sessile morphology with their sizes ranging from 0.5 to 15 mm in diameter. Their histopathology was characterized by elongated and dilated tubular structures with a moderate stromal cell expansion (Fig. 1, BCitation and C). Although the epithelium that lined polyp glands were mostly hyperplastic showing little cellular atypia (Fig. 1D)Citation , foci with obvious dysplastic signs were also observed occasionally with nuclear pseudostratification (Fig. 1E)Citation or abundant mucinous adenocarcinoma cells, including signet ring cells (Fig. 1, F and G)Citation . At the same time, some infiltrations of eosinophils and plasma cells were observed (data not shown).


View this table:
[in this window]
[in a new window]

  		Table 1 Gastrointestinal polyps in Smad4 heterozygotes

 


View larger version (101K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. Gastric polyps in the Smad4 knockout heterozygous mice. A, dissection micrograph of the stomach from an 89-week-old mouse opened along the greater curvature. Note the polyp (arrow) in the pyloric region (P). C, cardia; D, duodenum. B-E, sections of the same polyp shown in (A). B, section of the polyp through the part extending into the duodenum (D). Low magnification; H&E. C, a higher magnification field of the polyp section in (B). D, another field of the same section as in (B) showing hyperplastic glands. E, another field of the same section as in (B) showing dysplastic changes in the pit epithelium. F and G, sections of another gastric polyp from an 85-week-old heterozygote stained with both periodic acid-Schiff reagent and Alcian blue, showing an area of adenocarcinoma. Arrows in G point to signet ring cells. Bars: A, 5 mm; B, 2 mm; C and F, 200 µm; D and E, 50 µm; and G, 25 µm.

 
Interestingly, similar polyps were found in the duodenum as well in mice >50 weeks, especially between the gastric pylorus and the duodenal papilla of Vater (Table 1)Citation . Such polyps were not found in the wild-type littermates. The polyp multiplicity in the heterozygotes increased with age up to >15, in mice between 65 and 85 weeks of age. Under a dissection microscope, the duodenal polyps had a sessile morphology (Fig. 2A)Citation , and they were sometimes buried in the epithelial surface (Fig. 2B)Citation . These duodenal polyps included some small "nascent" ones, the histological pictures of which showed mostly hyperplastic epithelium with minimal cellular atypia. However, some foci were found showing abundant mitotic figures and nuclear pseudostratification, with crowding of the crypts (Fig. 2C)Citation . Because of recent reports that a subset of familial juvenile polyposis kindreds carries germ-line mutations in the SMAD4 gene (11 , 12) , we carefully compared the pathological characteristics of the gastric and duodenal polyps with those of human juvenile polyps. As in human juvenile polyposis, numerous eosinophils (Fig. 2D)Citation as well as plasma cells were observed, although the extent of the stromal expansion was much less in the mouse polyps, showing less granulation and less infiltration of lymphocytes. These inflammatory pictures are characteristic of the human juvenile polyposis (22) , although the subset of juvenile polyposis that carry SMAD4 germ-line mutations may be limited to a relatively small fraction (23) . In addition, some villi in the duodenum showed an aberrant appearance under a dissection microscope (Fig. 2E)Citation . Such "aberrant villi" turned out to have elongated crypt necks, as shown in Fig. 2FCitation .



View larger version (110K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. Early duodenal polyps in a Smad4 heterozygous mouse of 50 weeks of age. A, dissection micrograph of a nascent polyp. B, a low power micrograph of a section containing three early polyps (arrows; H&E). C and D, higher magnification fields of the polyp shown in B (H&E). Note the mitotic figures (arrows) and pseudostratified nuclei in C and abundant eosinophils (arrows) in D. E and F, "aberrant villi" found in the duodenum of a 65-week-old heterozygote. A dissection micrograph with the aberrant villi (arrows) is shown in E, whereas their section is shown in F. *, note the elongated crypt necks (H&E). Bars: A, 0.5 mm; B and E, 200 µm; C, 50 µm; D, 25 µm; and F, 100 µm.

 
To investigate whether the polyps were initiated because of LOH of the Smad4 gene, we isolated the epithelial layer from polyps of 1.5-year-old heterozygotes and determined the Smad4 genotype by PCR. The results in Fig. 3ACitation showed unambiguous LOH in all four polyp epithelial samples. To confirm the LOH histologically, we further stained polyp sections with antibodies against Smad4 NH2- and COOH-terminal peptides, respectively. As shown in Fig. 3BCitation , the polyp epithelium was not stained by these antibodies, whereas the adjoining normal epithelium was. The same result was obtained with the nascent duodenal polyps as well (Fig. 3C)Citation . Accordingly, the Smad4 LOH is one of the earliest events in polyp formation and likely to be the triggering event for both stomach and duodenal polyp initiation.



View larger version (137K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. Smad4 gene LOH and histopathological characterization of the gastric and duodenal polyps. A, a PCR-based genotyping of the Smad4 gene. Lanes N1-N3, epithelial samples from the normal mucosa; Lanes T1-T4, epithelial cells collected from four independent gastric polyps from four heterozygotes. Right, KO and WT point to the positions of the bands amplified from the knockout and wild-type Smad4 alleles (1.1 and 1.0 kb), respectively. Lane M was loaded with size markers. B and C, immunohistochemical staining for the SMAD4 protein in sections from a large gastric polyp (B) and a nascent duodenal polyp (arrow in C). Shown here are pictures stained with the antibody against the COOH-terminal peptide. Note that the polyp epithelia are not stained, whereas the normal epithelia are. D and E, immunohistochemical staining for {beta}-catenin in a Smad4 heterozygote gastric polyp and an Apc{Delta}716 heterozygote intestinal polyp, respectively. Note the nuclear staining in the polyp adenoma epithelium in E. Bars: B, 200 µm; C,40 µm; D and E, 75 µm.

 
It has been established that loss of Apc heterozygosity plays a key role in polyp initiation in Apc{Delta}716 knockout mice (16) . APC protein binds to {beta}-catenin and stimulates phosphorylation of {beta}-catenin by GSK3{beta}, one of the effectors in the Wnt signaling pathway (24) . If {beta}-catenin phosphorylation by GSK3{beta} is blocked by an Apc mutation, unphosphorylated and therefore stable {beta}-catenin accumulates, moves into the nucleus, and activates a new set of genes. To rule out the possibility that the Wnt pathway was activated by either Apc or {beta}-catenin gene mutations in the Smad4 mutant polyps, the subcellular localization of {beta}-catenin was determined by immunohistochemical staining. As shown in Fig. 3DCitation , we could not detect any nuclear localization of {beta}-catenin in the polyps of the Smad4 heterozygotes. On the other hand, a prominent nuclear staining was observed in the polyp epithelium of Apc{Delta}716 knockout mice (Fig. 3E)Citation . We also determined the sequence of the {beta}-catenin gene for exon 3 that contained the serine and threonine residues to be phosphorylated by GSK3{beta} and responsible for its rapid degradation and the subsequent suppression of the Wnt signaling pathway (24) . But we could not find any such {beta}-catenin mutations in the polyp epithelial cells (data not shown).

To examine the possibility of additional mutations in other genes that may be responsible for the polyp formation in the Smad4 heterozygous mice, we determined the sequences of the mutational hot spots at codons 12, 13, and 61 of Kirsten-Ras (Kras2), Harvey-Ras (Hras1), and N-Ras (Nras) genes but did not find any mutations (data not shown). We also determined the sequence of the central two-thirds (all exons other than 1, 4, or 9) of the p53 gene (Trp53) coding region that contained all mutational hot spots, without any mutations found (data not shown). Because another subset of familial juvenile polyposis was reported to carry germ-line mutations in the PTEN gene (25 , 26) , a gene encoding a phosphatidylinositol 3,4,5-phosphate phosphatase (27, 28, 29) , whose germ-line mutations are responsible also for Cowden disease (13 , 30) , we further investigated its mouse homologue Pten in the polyps of the Smad4 heterozygotes. However, we found neither LOH nor mutations in the coding sequence in any polyp DNA samples (data not shown).


   Discussion
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
REFERENCES
 
The similarities between the polyps in Smad4 heterozygous mice and those in human juvenile polyposis are more important than the differences. Although juvenile polyposis primarily affects the colon, at times it involves the entire gastrointestinal tract or presents as isolated gastric juvenile polyposis. Polyps may be present in early infancy or, more commonly, are discovered in childhood or early adulthood (31) . Histologically, juvenile polyps are characterized by abundant stroma infiltrated by a variable number of lymphocytes, plasma cells, neutrophils, and eosinophils and by dilated, often cystic, mucinous glands (31) . Familial juvenile polyposis predisposes to gastrointestinal cancer and possibly to pancreatic cancer (32, 33, 34) . In fact, the gastric and duodenal polyps in the Smad4 heterozygous mice resembled human juvenile polyps because of their moderate stromal cell expansion and prominent infiltrations by eosinophils and plasma cells. In addition, we have found some foci showing clear signs of adenocarcinoma with signet ring cells. The differences of the mouse disease from the human juvenile polyposis are the onset of the disease late in the mouse life (mostly >1 year) and relatively moderate pathological pictures, which can be explained by the less advanced state of the disease than those found clinically in most human juvenile polyposis.

Although juvenile polyps are often classified as hamartomatous polyps compared with adenomatous polyps (10) , most pathologists have interpreted juvenile polyps as inflammatory lesions with reparative changes (22) . Hamartomas are nonneoplastic nodules composed of an abnormal overgrowth of indigenous cell types with evidence of an underlying developmental etiology (35) . For example, we demonstrated recently that hamartomatous polyps develop in the cecum and the proximal colon of mice heterozygous for the Cdx2 gene. The tumors started to develop as outpocketing pouches at 11.5 days of gestation and formed partial duplications of the gut, which were contained later as hamartomatous polyps (36) . The polyps in the Smad4 heterozygous mice, however, were not such hamartomas but developed late in their lives and more appropriately described as inflammatory polyps.

Recently, it was reported that another subset of juvenile polyposis patients carried germ-line mutations in the PTEN gene (25) , although three earlier reports found no evidence of germ-line PTEN mutations in 21 juvenile polyposis syndrome families and 16 sporadic cases (37) . On the other hand, germ-line mutations in the PTEN gene have been found in two related autosomal dominant hamartomatous polyposis syndromes, Cowden disease and Bannayan-Ruvalcaba-Riley syndrome (13 , 14) . Although Cowden disease and its related syndromes predispose to malignant cancer of the breast and the thyroid, the polyposis in the gastrointestinal tract is of benign nature. In contrast, the juvenile polyps of the gastrointestinal tract are reported to predispose to malignant changes in more than one-half of cases (32 , 33) . Accordingly, questions arise whether mutations in the same gene can cause two separate disease entities, or the diagnosis for these diseases may not always be clear and unambiguous. In this regard, it is worth noting that heterozygous mice for the Pten gene knockout mutation show hyperplastic-neoplastic changes in the prostate, skin, and colon, which are more characteristic of Cowden disease and related syndromes than those of juvenile polyposis (37) .

In conclusion, we have demonstrated that Smad4 heterozygous mice develop gastric and duodenal polyps because of LOH of the Smad4 gene late in their lives. This animal model should provide a useful means to investigate and develop treatment for a subset of the human familial juvenile polyposis that carries germ-line SMAD4 mutations.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by the Joint Research Fund between the University of Tokyo and Banyu Pharmaceutical Co. and by grants from Monbusho (Ministry of Education, Science, Sports and Culture) and Koseisho (Ministry of Health and Welfare), Japan. Back

2 To whom requests for reprints should be addressed, at Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-5841-4859; Fax: 81-3-5841-4778; E-mail: taketo{at}mol.f.u-tokyo.ac.jp Back

3 The abbreviations used are: TGF, transforming growth factor; LOH, loss of heterozygosity; GSK, glycogen synthase kinase. Back

Received 8/ 9/99. Accepted 10/29/99.


   REFERENCES
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Hahn S. A., Schutte M., Hoque A. T., Moskaluk C. A., da Costa L. T., Rozenblum E., Weinstein C. L., Fischer A., Yeo C. J., Hruban R. H., Kern S. E. DPC4, a candidate tumor suppressor gene at human chromosome at 18q21.1. Science (Washington DC), 271: 350-353, 1996.[Abstract]
  2. Riggins G. J., Thiagalingam S., Rozenblum E., Weinstein C. L., Kern S. E., Hamilton S. R., Willson J. K., Markowitz S. D., Kinzler K. W., Vogelstein B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.[Medline]
  3. Zhang V., Feng X. H., Wu R. V., Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-{beta} response. Nature (Lond.), 383: 168-172, 1996.[Medline]
  4. Massagué J., Hata A., Liu F. TGF-{beta} signalling through the Smad pathway. Trends. Cell Biol., 7: 187-192, 1997.
  5. Massagué J. TGF{beta} signal transduction. Annu. Rev. Biochem., 67: 753-791, 1998.[Medline]
  6. Fynan T. M., Reiss M. Resistance to inhibition of cell growth by transforming growth factor {beta} and its role in oncogenesis. Crit. Rev. Oncol., 4: 493-540, 1993.
  7. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R. S., Zborowska E., Kinzler K. W., Vogelstein B., Brattain M., Willson J. K. V. Inactivation of the type II TGF{beta} receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.[Abstract/Free Full Text]
  8. Miyaki M., Iijima T., Konishi M., Sakai K., Ishii A., Yasuno M., Hishima T., Koike M., Shitara N., Iwama T., Utsunomiya J., Kuroki T., Mori T. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene, 18: 3098-3103, 1999.[Medline]
  9. Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M. F., Taketo M. M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell, 92: 645-656, 1998.[Medline]
  10. Haggit R. C., Reid B. J. Hereditary gastrointestinal polyposis syndromes. Am. J. Surg. Pathol., 10: 871-887, 1986.[Medline]
  11. Howe J. R., Roth S., Ringold J. C., Summers R. W., Jarvinen H. J., Sistonen P., Tomlinson I. P., Houlston R. S., Bevan S., Mitros F. A., Stone E. M., Aaltonen L. A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (Washington DC), 280: 1086-1088, 1998.[Abstract/Free Full Text]
  12. Friedl W., Kruse R., Uhlhaas S., Stolte M., Schartmann B., Keller K. M., Jungck M., Stern M., Loff S., Back W., Propping P., Jenne D. E. Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer, 25: 403-406, 1999.[Medline]
  13. Liaw D., Marsh D. J., Li J., Dahia P. L. M., Wang S. I., Zheng Z., Bose S., Call K. M., Tsou H. C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.[Medline]
  14. Marsh D. J., Dahia P. L., Zheng Z., Liaw D., Parsons R., Gorlin R. J., Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.[Medline]
  15. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P. Pten is essential for embryonic development and tumor suppression. Nat. Genet., 19: 348-355, 1998.[Medline]
  16. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncation Apc gene. Proc. Natl. Acad. Sci. USA, 92: 4482-4486, 1995.[Abstract/Free Full Text]
  17. Oshima H., Oshima M., Kobayashi M., Tsutsumi M., Taketo M. M. Morphological and molecular processes of polyp formation in Apc{Delta}716 knockout mice. Cancer Res., 57: 1644-1649, 1997.[Abstract/Free Full Text]
  18. Mowry R. W. The special value of methods that color both acidic and vicinal hydroxyl groups in the histochemical study of mucins. Ann. NY Acad. Sci., 106: 402-423, 1963.
  19. van Kranen H. J., de Gruijl F. R., de Vries A., Sontag Y., Wester P. W., Senden H. C., Rozemuller E., van Kreijl C. F. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis, 16: 1141-1147, 1995.[Abstract/Free Full Text]
  20. Smits R., Kartheuser A., Jagmohan-Changur S., Leblanc V., Breukel C., de Vries A., van Kranen H., van Krieken J. H., Williamson S., Edelmann W., Kucherlapati R., Khan P. M., Fodde R. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis, 18: 321-327, 1997.[Abstract/Free Full Text]
  21. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1947.[Abstract/Free Full Text]
  22. Fenoglio-Preiser C. M., Pascal R. R., Perzin K. H. Non-neoplastic polyps Hartman W. H. Sobin L. H. eds. . Tumors of the Intestines, : 31-67, Armed Forces Institute of Pathology Washington, DC 1990.
  23. Houlston R., Bevan S., Williams A., Young J., Dunlop M., Rozen P., Eng C., Markie D., Woodford-Richens K., Rodriguez-Bigas M. A., Leggett B., Neale K., Phillips R., Sheridan E., Hodgson S., Iwama T., Eccles D., Bodmer W., Tomlinson I. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum. Mol. Genet., 7: 1907-1912, 1999.[Abstract/Free Full Text]
  24. Polakis P. The oncogenic activation of {beta}-catenin. Curr. Opin. Genet. Dev., 9: 15-21, 1999.[Medline]
  25. Olschwang S., Serova-Sinilnikova O. M., Lenoir G. M., Thomas G. PTEN germ-line mutations in juvenile polyposis coli. Nat. Genet., 18: 12-14, 1998.[Medline]
  26. Lynch E. D., Ostermeyer E. A., Lee M. K., Arena J. F., Ji H., Dann J., Swisshelm K., Suchard D., MacLeod P. M., Kvinnsland S., Gjertsen B. T., Heimdal K., Lubs H., Moller P., King M. C. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet., 61: 1254-1260, 1997.[Medline]
  27. Maehama T., Dixon J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-phosphatase. J. Biol. Chem., 273: 13375-13378, 1998.[Abstract/Free Full Text]
  28. Furnari F., Huang H. J., Cavenee W. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res., 15: 5002-5008, 1998.
  29. Myers M. P., Pass I., Batty I. H., Van der Kaay J., Stolarov J. P., Hemmings B. A., Wigler M. H., Downes C. P., Tonks N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95: 13513-13518, 1998.[Abstract/Free Full Text]
  30. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H., Lindboe C. F., Fryns J. P., Sijmons R. H., Woods D. G., Mariman E. C., Padberg G. W., Kremer H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet., 6: 1383-1387, 1997.[Abstract/Free Full Text]
  31. Rotterdam H. Hyperplasias and benign epithelial tumors Rotterdam H. Enterline H. T. eds. . Pathology of the Stomach and Duodenum, : 117-141, Springer New York 1989.
  32. Howe J. R., Mitros F. A., Summers R. W. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann. Surg. Oncol., 5: 751-756, 1998.[Medline]
  33. Desai D. C., Neale K. F., Talbot I. C., Hodgson S. V., Phillips R. K. Juvenile polyposis. Br. J. Surg., 82: 14-17, 1995.[Medline]
  34. Walpole I. R., Cullity G. Juvenile polyposis: a case with early presentation and death attributable to adenocarcinoma of the pancreas. Am. J. Med. Genet., 32: 1-8, 1989.[Medline]
  35. Willis R. A. Hamartomas and hamartomatous syndromes Ed. 2 . The Borderland of Embryology and Pathology, : 351-392, Butterworths London 1962.
  36. Tamai Y., Nakajima R., Ishikawa T., Takaku K., Seldin M. F., Taketo M. M. Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice. Cancer Res., 59: 2965-2970, 1999.[Abstract/Free Full Text]
  37. Eng C., Peacocke M. PTEN and inherited hamartoma-cancer syndromes. Nat. Genet., 19: 223 1998.[Medline]



This article has been cited by other articles:


Home page
 BloodHome page
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda
Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice
Blood, October 15, 2007; 110(8): 3049 - 3055.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
G. Karlsson, U. Blank, J. L. Moody, M. Ehinger, S. Singbrant, C.-X. Deng, and S. Karlsson
Smad4 is critical for self-renewal of hematopoietic stem cells
J. Exp. Med., March 19, 2007; 204(3): 467 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L.-H. Wang, S.-H. Kim, J. H. Lee, Y.-L. Choi, Y. C. Kim, T. S. Park, Y.-C. Hong, C.-F. Wu, and Y. K. Shin
Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression
Clin. Cancer Res., January 1, 2007; 13(1): 102 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al.
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
Genes & Dev., November 15, 2006; 20(22): 3130 - 3146.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. M. Munoz, M. Upton, A. Rojas, M. K. Washington, L. Lin, A. Chytil, E. G. Sozmen, B. B. Madison, A. Pozzi, R. T. Moon, et al.
Transforming Growth Factor {beta} Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation.
Cancer Res., October 15, 2006; 66(20): 9837 - 9844.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Ge, V. Rajeev, P. Ray, E. Lattime, S. Rittling, S. Medicherla, A. Protter, A. Murphy, J. Chakravarty, S. Dugar, et al.
Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase In vivo.
Clin. Cancer Res., July 15, 2006; 12(14): 4315 - 4330.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
C. Oliveira, R. Seruca, and F. Carneiro
Genetics, Pathology, and Clinics of Familial Gastric Cancer
International Journal of Surgical Pathology, January 1, 2006; 14(1): 21 - 33.
[Abstract] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Ohgushi, S. Kuroki, H. Fukamachi, L. A. O'Reilly, K. Kuida, A. Strasser, and S. Yonehara
Transforming Growth Factor {beta}-Dependent Sequential Activation of Smad, Bim, and Caspase-9 Mediates Physiological Apoptosis in Gastric Epithelial Cells
Mol. Cell. Biol., November 15, 2005; 25(22): 10017 - 10028.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. Jazag, F. Kanai, H. Ijichi, K. Tateishi, T. Ikenoue, Y. Tanaka, M. Ohta, J. Imamura, B. Guleng, Y. Asaoka, et al.
Single small-interfering RNA expression vector for silencing multiple transforming growth factor-{beta} pathway components
Nucleic Acids Res., August 19, 2005; 33(15): e131 - e131.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
G. C. Chu, N. R. Dunn, D. C. Anderson, L. Oxburgh, and E. J. Robertson
Differential requirements for Smad4 in TGF{beta}-dependent patterning of the early mouse embryo
Development, August 1, 2004; 131(15): 3501 - 3512.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A.-P. G. Haramis, H. Begthel, M. van den Born, J. van Es, S. Jonkheer, G. J. A. Offerhaus, and H. Clevers
De Novo Crypt Formation and Juvenile Polyposis on BMP Inhibition in Mouse Intestine
Science, March 12, 2004; 303(5664): 1684 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F.-F. Chu, R. S. Esworthy, P. G. Chu, J. A. Longmate, M. M. Huycke, S. Wilczynski, and J. H. Doroshow
Bacteria-Induced Intestinal Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes
Cancer Res., February 1, 2004; 64(3): 962 - 968.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
K. C. Flanders and J. K. Burmester
Medical Applications of Transforming Growth Factor-{beta}
Clin. Med. Res., January 1, 2003; 1(1): 13 - 20.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. V. Biankin, A. L. Morey, C.-S. Lee, J. G. Kench, S. A. Biankin, H. C. Hook, D. R. Head, T. B. Hugh, R. L. Sutherland, and S. M. Henshall
DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma
J. Clin. Oncol., December 1, 2002; 20(23): 4531 - 4542.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al.
Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells
Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Hamamoto, H. Beppu, H. Okada, M. Kawabata, T. Kitamura, K. Miyazono, and M. Kato
Compound Disruption of Smad2 Accelerates Malignant Progression of Intestinal Tumors in Apc Knockout Mice
Cancer Res., October 15, 2002; 62(20): 5955 - 5961.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Miyoshi, M. Nakau, T.-o Ishikawa, M. F. Seldin, M. Oshima, and M. M. Taketo
Gastrointestinal Hamartomatous Polyposis in Lkb1 Heterozygous Knockout Mice
Cancer Res., April 1, 2002; 62(8): 2261 - 2266.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. L. Woodford-Richens, A. J. Rowan, R. Poulsom, S. Bevan, R. Salovaara, L. A. Aaltonen, R. S. Houlston, N. A. Wright, and I. P. M. Tomlinson
Comprehensive Analysis of SMAD4 Mutations and Protein Expression in Juvenile Polyposis : Evidence for a Distinct Genetic Pathway and Polyp Morphology in SMAD4 Mutation Carriers
Am. J. Pathol., October 1, 2001; 159(4): 1293 - 1300.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
C. Xiangming, S. Natsugoe, S. Takao, S. Hokita, S. Ishigami, G. Tanabe, M. Baba, K. Kuroshima, and T. Aikou
Preserved Smad4 Expression in the Transforming Growth Factor {beta} Signaling Pathway Is a Favorable Prognostic Factor in Patients with Advanced Gastric Cancer
Clin. Cancer Res., February 1, 2001; 7(2): 277 - 282.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
M. P. de Caestecker, E. Piek, and A. B. Roberts
Role of Transforming Growth Factor-{beta} Signaling in Cancer
J Natl Cancer Inst, September 6, 2000; 92(17): 1388 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Saha, P. K. Datta, and R. D. Beauchamp
Oncogenic Ras Represses Transforming Growth Factor-beta /Smad Signaling by Degrading Tumor Suppressor Smad4
J. Biol. Chem., July 27, 2001; 276(31): 29531 - 29537.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takaku, K.
Right arrow Articles by Taketo, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takaku, K.
Right arrow Articles by Taketo, M. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online